Related Experiment Video
Updated: Nov 11, 2025

08:04
Murine Fetal Echocardiography
Published on: February 15, 2013
17.7K
[Value of chromosomal microarray analysis for fetuses with duodenal obstruction]
Wenwen Zhang1, Kun Du, Fang Fu
1Center of Prenatal Diagnosis, Guangzhou Women and Children's Medical Center Affiliated to Guangzhou Medical University, Guangzhou, Guangdong 510623, China. canliao6008@163.com.
Summary
Chromosomal microarray analysis (CMA) detects genomic abnormalities in fetal duodenal obstruction (DO). This prenatal diagnosis is crucial for genetic counseling and determining fetal prognosis.
Area of Science:
- Genetics
- Prenatal Diagnostics
- Medical Genetics
Background:
- Fetal duodenal obstruction (DO) is a significant congenital anomaly.
- Accurate prenatal diagnosis of DO is essential for appropriate management and counseling.
- The genetic underpinnings of DO require further investigation.
Purpose of the Study:
- To evaluate the diagnostic utility of chromosomal microarray analysis (CMA) in fetuses diagnosed with duodenal obstruction (DO).
- To identify genomic abnormalities associated with fetal DO.
- To assess the correlation between genetic findings and pregnancy outcomes.
Main Methods:
- Fifty-one fetuses with ultrasound-identified DO were enrolled.
- Samples (amniotic fluid or umbilical blood) underwent CMA.
- Pregnancy outcomes were meticulously followed for all participants.
Main Results:
- Genomic abnormalities were detected in 15.7% of fetuses with DO.
- Identified abnormalities included chromosomal aneuploidies and copy number variations (CNVs), such as 17q12 microduplication and various 13q deletions/duplications.
- Candidate genes like EDNRB and HNF1B were implicated in fetal DO.
- No significant difference in CNV detection rates was observed between isolated DO and DO with other anomalies.
Conclusions:
- A significant correlation exists between fetal DO and genomic copy number variations.
- CMA is a valuable tool for detecting microdeletions/microduplications in fetal DO.
- Prenatal diagnosis using CMA aids in genetic counseling and prognosis assessment for affected fetuses.

